A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
about
Diagnostic and therapeutic management of hepatocellular carcinomaCan serum glypican-3 be a biomarker for effective diagnosis of hepatocellular carcinoma? A meta-analysis of the literaturePrognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysisEnhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells.Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma.Heparan sulfate and heparanase as modulators of breast cancer progressionUpdate on biomarkers of hepatocellular carcinoma.Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis.Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3.Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?Cytokeratin-18 in Diagnosis of HCC in Patients with Liver CirrhosisMyofibroblasts are important contributors to human hepatocellular carcinoma: evidence for tumor promotion by proteome profiling.Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3.Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
P2860
Q26999043-D9D07621-5DFA-4425-AFA0-05FEFDD1A920Q27023427-29F083B1-039F-46DA-BE26-3A879A99412BQ33661257-39F7BFCD-2DCB-4D15-94E0-6302A11D950EQ35201631-97FBF730-AFE7-406D-9D34-612A7F37A396Q37031710-0209A816-D1FF-48B9-8A80-D3D50EA73A5DQ37105315-F15EC6DD-9EE6-42F7-96EE-D353E7575015Q38166133-B4CF2EEE-D107-4FCE-B107-50405427AFB3Q38366584-08864F00-2DD5-4580-A0AC-3B53786C4FBCQ38637305-7445C205-1AEC-4D06-90F7-D83AF54A3D64Q38692450-274073C1-1A37-4790-B836-0D95F35CB01FQ38985923-04D779B1-5163-4270-9767-2211814F5FB7Q39062912-43BB2BFA-2F39-4641-A498-A84ECC07A145Q39096520-32374FB5-98A6-432F-8DCF-7F260BA17968Q39335058-0870F2C7-BBEA-4A87-95AA-5E2ECEA7DCDBQ41550210-5720D947-7B58-487A-A927-D8A9B7E495BFQ53585495-8FB0B638-5FF1-4F9E-8292-F6BEB17AB3D8Q55189641-CDFF9D20-7E55-42A6-BE3F-1585F6BAF34E
P2860
A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
A comparison of glypican-3 wit ...... ar carcinoma: a meta-analysis.
@ast
A comparison of glypican-3 wit ...... ar carcinoma: a meta-analysis.
@en
A comparison of glypican-3 wit ...... ar carcinoma: a meta-analysis.
@nl
type
label
A comparison of glypican-3 wit ...... ar carcinoma: a meta-analysis.
@ast
A comparison of glypican-3 wit ...... ar carcinoma: a meta-analysis.
@en
A comparison of glypican-3 wit ...... ar carcinoma: a meta-analysis.
@nl
prefLabel
A comparison of glypican-3 wit ...... ar carcinoma: a meta-analysis.
@ast
A comparison of glypican-3 wit ...... ar carcinoma: a meta-analysis.
@en
A comparison of glypican-3 wit ...... ar carcinoma: a meta-analysis.
@nl
P2093
P2860
P1476
A comparison of glypican-3 wit ...... ar carcinoma: a meta-analysis.
@en
P2093
Liang Zhou
Yuming Wang
Zhehui Yan
P2860
P2888
P304
P356
10.1007/S00432-013-1458-5
P577
2013-06-07T00:00:00Z